Fate Therapeutics (NASDAQ:FATE) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Fate Therapeutics beat estimated earnings by 10.53%, reporting an EPS of $-0.68 versus an estimate of $-0.76.
Revenue was up $7.27 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.05 which was followed by a 0.38% drop in the share price the next day.
To track all earnings releases for Fate Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
